Researchers searching for buy MOTS-c online should evaluate MOTS-c as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, storage information, and supplier evaluation. This guide explains how to evaluate MOTS-c 20mg for controlled research procurement through Pure Lab Peptides while keeping all commercial intent limited to qualified laboratory research sourcing.
Fast Answer: buy MOTS-c online for laboratory research
Researchers can buy MOTS-c online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
What Does “Buy MOTS-c Online” Mean in a Research Context?
The phrase buy MOTS-c online is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the searcher is a qualified researcher, laboratory buyer, technical procurement lead, or research institution evaluating whether a MOTS-c research material is properly documented before purchase.
Research-use-only sourcing should focus on the evidence that supports controlled laboratory recordkeeping: clear RUO labeling, batch-specific certificate of analysis access, product-name consistency, lot-level traceability, purity documentation, identity testing, and storage and handling documentation. FDA guidance for RUO and investigational-use labeling in the IVD context emphasizes that labeling should remain consistent with intended use, while 21 CFR 809.10 distinguishes research-only labeling from diagnostic-use positioning [1] [2].
For MOTS-c research procurement, supplier transparency matters because a commercial product page can either support RUO review or blur the line with non-research positioning. Researchers should favor documentation, analytical testing, and conservative labeling over promotional claims.
MOTS-c Research Material Overview
MOTS-c is discussed in scientific databases and literature as a mitochondrial-derived peptide associated with the mitochondrial open reading frame of the 12S rRNA region. PubChem lists MOTS-c with molecular formula C101H152N28O22S2, while UniProt identifies the human MOTS-c entry as a 16-amino-acid mitochondrial-derived peptide associated with MT-RNR1 [3] [4]. The human mitochondrial genome was originally characterized as a compact genome containing rRNA, tRNA, and protein-coding features, which provides background for later work on small mitochondrial open reading frames [5].
In laboratory procurement language, MOTS-c should be treated as a MOTS-c research material rather than a consumer product. Published literature describes MOTS-c as a 16-amino-acid peptide first reported in mitochondrial-pathway research and later examined in cellular and model-based studies [6]. Other work has examined nuclear translocation and gene-expression models under metabolic stress conditions, which is relevant as scientific context but not as product-use guidance [7].
Reviews of mitochondrial-derived peptides describe MOTS-c alongside humanin and SHLP-family peptides as part of an emerging literature on small open reading frames, peptide identity, and mitochondrial-nuclear signaling models [8] [9] [10] [11]. Metabolic pathway literature should not be translated into weight-loss, performance, or wellness claims for RUO materials.
Why Researchers Search “Buy MOTS-c Online”
Researchers may search buy MOTS-c online when comparing RUO product availability, supplier documentation, product form, analytical data, and COA access. This search behavior does not mean the page should provide consumer buying advice. Instead, it should help laboratory teams decide whether a source provides enough documentation for controlled research procurement.
When teams search to buy MOTS-c, the most relevant evaluation points include MOTS-c COA access, MOTS-c purity documentation, MOTS-c identity testing, product label consistency, lot number matching, and MOTS-c supplier documentation. A qualified procurement workflow should also check whether the supplier avoids dosing language, therapeutic framing, or personal-use claims.
For Pure Lab Peptides, the commercial keyword should be interpreted as buy MOTS-c online for laboratory research with COA documentation, not as a wellness, treatment, or self-use search.
Research Procurement Checklist for MOTS-c
- Verify that MOTS-c is labeled for research use only.
- Review the batch-specific certificate of analysis before procurement.
- Confirm that the MOTS-c COA includes identity and purity documentation.
- Check whether HPLC, LC-MS, mass spectrometry, or another analytical method is listed.
- Compare the product name, lot number, and documentation for consistency.
- Assess whether the supplier avoids dosing, injection, therapeutic, or human-use claims.
- Document storage and handling information in laboratory records.
- Evaluate whether lyophilized powder form matches the needs of the research workflow.
- Confirm that the product is not marketed for human or animal consumption.
MOTS-c Quality Signals to Review Before Buying Online
Researchers who buy MOTS-c online for laboratory research should evaluate the supplier’s quality signals before selecting a source. Testing and documentation frameworks such as ISO/IEC 17025 emphasize competent and consistent laboratory operations, while analytical-method guidance from FDA and ICH highlights the importance of method suitability, validation principles, and quality-focused analytical development [12] [13] [14] [15].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the available batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data listed in the documentation | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
COA, Purity, and Identity Documentation
A certificate of analysis should help researchers connect a specific lot of MOTS-c to specific analytical documentation. NIST reference-material resources describe certificates as documentation that can report certified property values or material information, which illustrates why laboratory documentation should be specific rather than generic [16].
For MOTS-c purity documentation, researchers should look for compound name, lot number, test date, stated purity percentage, testing method, identity confirmation, product form, and storage documentation. For peptide identity review, HPLC can support separation and purity assessment, while mass spectrometry and LC-MS methods can support molecular identity and sequence-related evaluation in peptide workflows [17] [18].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. Targeted peptide-measurement literature also emphasizes fit-for-purpose assay development, well-characterized peptide materials, and clear storage and handling procedures for peptide standards [19] [20]. LC-MS impurity-characterization literature further supports the value of combining chromatographic and mass-based information when reviewing synthetic peptide materials [21]. Lyophilization literature provides general background on solid protein and peptide material stabilization, but storage instructions should always come from the supplier’s documented handling information for the specific lot [22].
flowchart TD
A[Receive product and COA] --> B{RUO labeling present?}
B -- No --> C[Flag procurement gap]
B -- Yes --> D{Lot number matches across label and COA?}
D -- No --> E[Request batch-specific documentation]
D -- Yes --> F{Identity supported by analytical method?}
F -- No --> G[Request HPLC, LC-MS, or equivalent]
F -- Yes --> H[Proceed to laboratory documentation and storage]
Research Literature Context
Published literature has examined MOTS-c in mitochondrial-derived peptide research, small open reading frame biology, metabolic-stress signaling models, and mitochondrial-nuclear communication. These research areas provide scientific context for compound identity and literature classification, not instructions for handling, preparing, or applying RUO materials.
Several reviews summarize MOTS-c literature as a developing field involving mitochondrial-derived peptides, retrograde signaling, and pathway-level models [23] [24] [25]. The primary literature includes in vitro and preclinical model work, while some publications discuss clinical-context or biomarker-oriented research outside the scope of RUO product use. Published clinical literature should not be interpreted as use guidance for RUO materials.
For procurement teams, the practical takeaway is narrow: literature may help identify the compound class and research category, but it does not replace COA review, lot matching, purity documentation, or identity testing. Published literature should not be converted into claims about outcomes, expected effects, or research-material use.
Evidence Landscape
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, and classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | Mitochondrial-derived peptide research, mitochondrial-nuclear signaling models, and AMPK-related pathway literature | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
Claim Boundary Table
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “MOTS-c is discussed in published research related to mitochondrial-derived peptide pathways.” | Describes literature context without making a product claim | “MOTS-c helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy MOTS-c for results.” |
| “Pure Lab Peptides supplies MOTS-c as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies MOTS-c for therapy.” |
| “The phrase buy MOTS-c online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy MOTS-c online for personal use.” |
| “MOTS-c supplier documentation should be reviewed at the lot level.” | Emphasizes traceability and records | “Supplier claims can replace analytical documentation.” |
How Pure Lab Peptides Presents MOTS-c
Pure Lab Peptides presents MOTS-c 20mg as a research-use-only material. The product is positioned with a ≥99% purity claim, lyophilized powder form, available batch-specific COA documentation, storage and handling information, lot-level traceability, and product-page documentation for laboratory review.
Researchers should review the Pure Lab Peptides MOTS-c research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Procurement teams comparing sources may also review the broader research peptide collection to evaluate supplier consistency across related RUO materials.
Pure Lab Peptides should be evaluated from a documentation-first perspective: MOTS-c research-use-only labeling, MOTS-c COA availability, MOTS-c purity documentation, MOTS-c identity testing, storage information, and supplier transparency are the relevant buying factors.
Common Misunderstandings About Buying MOTS-c Online
Misunderstanding: “Buy MOTS-c online” means personal use
Buy MOTS-c online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Misunderstanding: Published literature equals product-use guidance
Published literature may describe MOTS-c in mitochondrial-derived peptide studies, pathway models, or broader review articles. That literature is scientific context only. It does not provide instructions for RUO product use, and it should not be converted into promotional claims about a research material.
Misunderstanding: Purity percentage alone proves identity
A purity value is only one part of documentation review. Researchers should evaluate the stated purity alongside compound name, lot number, test method, identity data, product form, and supplier documentation. MOTS-c identity testing and MOTS-c purity documentation should be reviewed together.
Misunderstanding: COA documentation does not need to be batch-specific
A COA is most useful when it is tied to the specific batch under review. Lot-level traceability helps researchers match the label, product record, and analytical documentation. A generic quality statement is not a substitute for batch-specific documentation.
Misunderstanding: RUO labeling supports human or animal use
Research-use-only labeling narrows the intended context to controlled laboratory research. It does not support human consumption, animal consumption, diagnostic use, clinical use, veterinary use, or personal-use positioning. RUO language should be consistent across product pages, labels, and documentation.
Misunderstanding: Supplier claims can replace analytical documentation
Supplier language should never replace analytical records. Researchers should prioritize batch-specific COA review, identity data, purity method, lot matching, and storage documentation over broad claims. Transparent documentation is the core of MOTS-c supplier documentation review.
FAQs About Buying MOTS-c Online for Research
Where can researchers buy MOTS-c online for laboratory research?
Researchers can buy MOTS-c online for laboratory research by reviewing suppliers that clearly present RUO labeling, product identity, purity documentation, batch-specific COA access, storage information, and lot traceability. Pure Lab Peptides provides a MOTS-c 20mg product page for qualified laboratory procurement review.
What should researchers check before buying MOTS-c online?
Before buying MOTS-c online, researchers should check RUO labeling, the available batch-specific COA, product-name consistency, lot number alignment, stated purity, analytical method, identity information, product form, and supplier language. The review should focus on documentation, not personal-use claims or outcome expectations.
Why does a COA matter when buying MOTS-c?
A MOTS-c COA matters because it connects a batch of research material to documented analytical information. Researchers should review the compound name, lot number, test date, purity result, identity method, and any chromatographic or mass-based data included in the documentation.
Is MOTS-c intended for human or animal consumption?
MOTS-c discussed on this page is not intended for human or animal consumption. The article addresses MOTS-c research-use-only procurement for controlled laboratory settings. It does not provide dosing, preparation, administration, clinical, veterinary, diagnostic, or personal-use guidance.
What does research use only mean for MOTS-c?
Research use only means MOTS-c is positioned as a laboratory research material for qualified research settings. RUO positioning should be reflected in labeling, product documentation, supplier language, and procurement records. It should not be interpreted as permission for consumer, clinical, or veterinary use.
How should published literature about MOTS-c be interpreted?
Published literature about MOTS-c should be interpreted as scientific context for compound classification, pathway research, and model design. It should not be treated as product-use guidance for RUO materials. Researchers should separate literature review from procurement review, COA verification, and lot-level documentation.
Next Steps
For research teams comparing MOTS-c suppliers, prioritize COA availability, transparent labeling, purity documentation, identity testing, storage information, and lot-level traceability. Review the Pure Lab Peptides MOTS-c product page for RUO labeling, purity information, and available batch-specific documentation.
References
- U.S. Food and Drug Administration. “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only.” FDA Guidance Document. 2013. fda.gov/regulatory-information/search-fda-guidance-documents/distribution-in-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only
- Electronic Code of Federal Regulations. “21 CFR 809.10 – Labeling for in vitro diagnostic products.” eCFR. Current. ecfr.gov/current/title-21/chapter-I/subchapter-H/part-809/subpart-B/section-809.10
- National Center for Biotechnology Information. “Mots-c.” PubChem Compound Database. Current. pubchem.ncbi.nlm.nih.gov/compound/Mots-c
- UniProt Consortium. “A0A0C5B5G6 – Mitochondrial-derived peptide MOTS-c.” UniProtKB. Current. uniprot.org/uniprotkb/A0A0C5B5G6/entry
- Anderson S, Bankier AT, Barrell BG, et al. “Sequence and organization of the human mitochondrial genome.” Nature. 1981. doi.org/10.1038/290457a0
- Lee C, Zeng J, Drew BG, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell Metabolism. 2015. doi.org/10.1016/j.cmet.2015.02.009
- Kim KH, Son JM, Benayoun BA, Lee C. “The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress.” Cell Metabolism. 2018. doi.org/10.1016/j.cmet.2018.06.008
- Lee C, Kim KH, Cohen P. “MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism.” Free Radical Biology and Medicine. 2016. doi.org/10.1016/j.freeradbiomed.2016.05.015
- Kim SJ, Xiao J, Wan J, Cohen P, Yen K. “Mitochondrially derived peptides as novel regulators of metabolism.” The Journal of Physiology. 2017. doi.org/10.1113/JP274472
- Miller B, Kim SJ, Kumagai H, Mehta HH, Xiang Y, Liu J, Yen K, Cohen P. “Peptides derived from small mitochondrial open reading frames.” Experimental Cell Research. 2020. doi.org/10.1016/j.yexcr.2020.112056
- Merry TL, Chan A, Woodhead JST, Reynolds JC, Kumagai H, Kim SJ, Lee C. “Mitochondrial-derived peptides in energy metabolism.” American Journal of Physiology-Endocrinology and Metabolism. 2020. doi.org/10.1152/ajpendo.00249.2020
- International Organization for Standardization. “ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories.” ISO. 2017. iso.org/standard/66912.html
- U.S. Food and Drug Administration. “Analytical Procedures and Methods Validation for Drugs and Biologics.” FDA Guidance Document. 2015. fda.gov/regulatory-information/search-fda-guidance-documents/analytical-procedures-and-methods-validation-drugs-and-biologics
- International Council for Harmonisation. “Q2(R2) Validation of Analytical Procedures.” ICH Harmonised Guideline. 2023. database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf
- International Council for Harmonisation. “Q14 Analytical Procedure Development.” ICH Harmonised Guideline. 2023. database.ich.org/sites/default/files/ICH_Q14_Guideline_2023_1116.pdf
- National Institute of Standards and Technology. “Reference materials.” NIST. Current. nist.gov/reference-materials
- Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. “HPLC analysis and purification of peptides.” Methods in Molecular Biology. 2007. doi.org/10.1007/978-1-59745-430-8_1
- Steen H, Mann M. “The ABC’s (and XYZ’s) of peptide sequencing.” Nature Reviews Molecular Cell Biology. 2004. doi.org/10.1038/nrm1468
- Carr SA, Abbatiello SE, Ackermann BL, et al. “Targeted peptide measurements in biology and medicine: Best practices for mass spectrometry-based assay development using a fit-for-purpose approach.” Molecular and Cellular Proteomics. 2014. doi.org/10.1074/mcp.M113.036095
- Hoofnagle AN, Whiteaker JR, Carr SA, et al. “Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays.” Clinical Chemistry. 2016. doi.org/10.1373/clinchem.2015.250563
- Lian Z, Wang J, Ji T, et al. “Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives.” Journal of the American Society for Mass Spectrometry. 2021. doi.org/10.1021/jasms.0c00479
- Wang W. “Lyophilization and development of solid protein pharmaceuticals.” International Journal of Pharmaceutics. 2000. doi.org/10.1016/S0378-5173(00)00423-3
- Wan W, Zhang L, Lin Y, Rao X, Wang X, Ying J. “Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging.” Journal of Translational Medicine. 2023. doi.org/10.1186/s12967-023-03885-2
- Mohtashami Z, Singh MK, Salimiaghdam N, et al. “MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.” International Journal of Molecular Sciences. 2022. doi.org/10.3390/ijms231911991
- Zheng Y, Wei X, Liu Y, et al. “MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.” Frontiers in Endocrinology. 2023. doi.org/10.3389/fendo.2023.1120533
Skip to content 
There are no reviews yet.